Background Children with cancer are frequently immunocompromised. While children are
generally thought to be at less risk of severe SARS-CoV-2 infection than adults …

Constitutional mismatch repair-deficiency: current problems and emerging therapeutic
strategies - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

With the development of empirically supported treatments over the decades, have youth
psychotherapies grown stronger? To investigate, we examined changes over time in …

Neuroblastoma (NB) is a common solid extracranial tumor developing in pediatric
populations. NB can spontaneously regress or grow and metastasize displaying resistance …

The purpose of this article is to explicate a conceptual framework for financial toxicity in
pediatric oncology to guide nursing practice and research. The framework is based on one …

CD47 is a cell-surface marker well recognized for its anti-phagocytic functions. As such, an
emerging avenue for targeted cancer therapies involves neutralizing the anti-phagocytic …

Pleuropulmonary blastoma (PPB), the most common primary malignant neoplasm of the
lung in childhood, occurs in the same early age group (0–6 years) as the other more …

The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type
of soft tissue sarcoma in children, is poor and no strategies have been identified to improve …

Childhood cancer survivors (CCS) are at an increased risk of endocrine disorders. Disorders
of the hypothalamic-pituitary-gonadal (HPG) axis are a particular concern because of their …

Background Research is crucial to improve treatment, survival and quality of life for children
with cancer. However, recruitment of children for research raises ethical challenges. The aim …